We are international
Donate
publications TEXT SIZE   
meeting highlights    back

KOS 2007: Role of Bortezomib in Myeloma Patients Eligible for High-Dose Therapy
By Sundar Jagannath, MD
Sundar Jagannath, MD
St. Vincent's Comprehensive Cancer Center
New York, NY, USA
06.27.07

Be the first to comment

 related articles